Further cost-effectiveness analysis of sequential TNF inhibitors for rheumatoid arthritis patients

Prepared by Dr Pelham Barton (West Midlands Health Technology Assessment Collaboration)

Further cost-effectiveness analysis of sequential TNF inhibitors for rheumatoid arthritis patients

Further cost-effectiveness analysis of sequential TNF inhibitors for rheumatoid arthritis patients
29 April 2008
(486.4 Kb 21 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 30 March 2010